We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Gene Silencing Masks the Malaria Parasite

By Biotechdaily staff writers
Posted on 28 Apr 2005
Researchers have identified a mechanism used by the malaria parasite Plasmodium falciparum to regulate the var gene responsible for the manufacture of the variable surface protein PfEMP1, which hides the parasite from the host's immune response. More...
While the P falciparum genome contains at least 50 var genes, only one is expressed at any given time, giving rise to a single version of the PfEMP1 protein.

Investigators at The Walter and Eliza Hall Institute of Medical Research (Melbourne, Australia) studied the region around the var gene by inserting a gene for drug resistance adjacent to it. They reported in the April 8, 2005, issue of Cell that a process of gene silencing was operating. In some parasites, the DNA region was active, and the parasites showed resistance to the drug. In others, the drug killed the parasites.

Gene silencing suggested the involvement SIR2 (silent information regulator 2) protein, which was known to play a role in gene silencing in yeast by modifying gene packaging. To learn what SIR2 was doing, the investigators developed a parasite line that lacked the SIR2 gene. "Silencing occurs by packaging up the DNA into a tight form and preventing it from being expressed. That tight packaging involves SIR2,” said senior author Dr. Alan Cowman, professor of infection and immunity at The Walter and Eliza Hall Institute of Medical Research.

Another potential control mechanism for gene silencing is compartmentalization. The investigators used fluorescence in situ hybridization (FISH), a technique that employs fluorescent-labeled probes specific for particular segments of DNA, to determine the position of var genes in "on” and "off” states. They found that there appeared to be discrete nuclear compartments that allowed gene expression to occur. When a var gene moved into this compartment, it became activated and its version of PfEMP1 was expressed.

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
D-Dimer Test
Epithod 616 D-Dimer Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.